MPV17 Gene Variant Mutation Presenting as Leucoencephalopathy with Peripheral Neuropathy

Ravindranadh Chowdary Mundlamuri1, Pradeep Divate2, Parthasarthy Satishchandra3

  • 1Department of Neurology, NIMHANS, Bengaluru, Karnataka, India.

Neurology India
|January 4, 2022
PubMed

Insights

Mitochondrial DNA depletion syndromes (MDS) are rare genetic disorders. This report details a novel MPV17 gene mutation in India causing neuropathy, leucoencephalopathy, and liver issues.

Area of Science:

  • Genetics
  • Neurology
  • Biochemistry

Background:

  • Mitochondrial DNA depletion syndromes (MDS) represent a group of rare genetic disorders characterized by decreased mitochondrial DNA copy number.
  • These syndromes exhibit significant genotypic and phenotypic heterogeneity, posing diagnostic challenges.

Observation:

  • This report presents the first case from India of a patient with a mutation in the MPV17 gene, which encodes a mitochondrial inner membrane protein.
  • The patient exhibited a complex clinical presentation including neuropathy and leucoencephalopathy.

Findings:

  • The MPV17 gene variant mutation was associated with subclinical hepatic dysfunction, highlighting the systemic impact of this genetic defect.
  • Detailed clinical and neuroimaging descriptions provide valuable insights into the phenotype of this specific MPV17 mutation.

Implications:

  • This case expands the known spectrum of MPV17 mutations and their clinical manifestations in MDS.
  • Early identification and characterization of such mutations are crucial for timely diagnosis and management of mitochondrial disorders.